Scarica l'app Stockscreener
0.339
4.82%
0.0156
Dopo l'orario di chiusura:
.34
0.001
+0.29%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$0.3234
Aprire:
$0.3275
Volume 24 ore:
400.58K
Relative Volume:
0.31
Capitalizzazione di mercato:
$14.05M
Reddito:
$1.50M
Utile/perdita netta:
$-64.59M
Rapporto P/E:
-0.203
EPS:
-1.67
Flusso di cassa netto:
$-55.17M
1 W Prestazione:
+3.96%
1M Prestazione:
+2.76%
6M Prestazione:
-33.27%
1 anno Prestazione:
-86.86%
Intervallo 1D:
$0.3275
$0.3529
Intervallo di 1 settimana:
$0.30
$0.3529
Portata 52W:
$0.2223
$4.79
Leap Therapeutics Inc Stock (LPTX) Company Profile
Nome
Leap Therapeutics Inc
Settore
Industria
Telefono
617 252 4343
Indirizzo
47 THORNDIKE STREET, CAMBRIDGE, MA
Confronta LPTX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LPTX
Leap Therapeutics Inc
|
0.339 | 13.40M | 1.50M | -64.59M | -55.17M | -1.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.92 | 99.42B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.55 | 58.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.52 | 56.35B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
646.60 | 39.02B | 3.06B | 1.28B | -614.78M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
307.51 | 34.25B | 3.81B | -644.79M | -669.77M | -6.24 |
Leap Therapeutics Inc Stock (LPTX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-29 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2025-01-29 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2021-10-04 | Iniziato | Mizuho | Buy |
| 2021-06-04 | Ripresa | Robert W. Baird | Outperform |
| 2020-06-29 | Iniziato | Piper Sandler | Overweight |
| 2020-02-11 | Iniziato | Robert W. Baird | Outperform |
| 2019-11-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-09-13 | Ripresa | Raymond James | Outperform |
| 2017-03-07 | Iniziato | Ladenburg Thalmann | Buy |
Mostra tutto
Leap Therapeutics Inc Borsa (LPTX) Ultime notizie
How to monitor Leap Therapeutics Inc. with trend dashboards2025 Buyback Activity & Entry Point Confirmation Alerts - Newser
Will Leap Therapeutics Inc. stock recover after recent dropMarket Rally & Smart Investment Allocation Tips - Newser
Published on: 2025-08-13 06:09:08 - Newser
Why Leap Therapeutics Inc. stock attracts strong analyst attentionPortfolio Value Report & Expert Approved Momentum Ideas - Newser
What data driven models say about Leap Therapeutics Inc.’s futureBull Run & Risk Controlled Swing Trade Alerts - Newser
Chart overlay techniques for tracking Leap Therapeutics Inc.Weekly Trading Summary & Expert Verified Movement Alerts - Newser
Published on: 2025-08-13 02:55:13 - Newser
Is Leap Therapeutics Inc. stock entering bullish territoryAnalyst Upgrade & Daily Stock Trend Reports - Newser
Relative strength of Leap Therapeutics Inc. in sector analysisEarnings Overview Report & Daily Profit Maximizing Trade Tips - Newser
Using R and stats models for Leap Therapeutics Inc. forecastingBreakout Screener With Alert Based Timing - Newser
Is Leap Therapeutics Inc. stock reversal real or fakeFree Confirmed Setup With Expert Accuracy - Newser
What earnings revisions data tells us about Leap Therapeutics Inc.Daily Market Momentum Summary and Strategy - Newser
Screener Results Flag Leap Therapeutics Inc. as OversoldQuick Gain Stock Watch With Indicators Reviewed - 선데이타임즈
What machine learning models say about Leap Therapeutics Inc.AI-Based Reversal Point Prediction Signal - Newser
How Leap Therapeutics Inc. stock performs during market volatilityExpert-Backed High Yield Stock Watchlist - Newser
What makes Leap Therapeutics Inc. stock price move sharplyFree ROI Driven Equity Selection With Safety - Newser
Does Leap Therapeutics Inc. qualify in momentum factor screeningDay Trading Setup and Momentum Analysis - Newser
Using data filters to optimize entry into Leap Therapeutics Inc.Stock Market Trend and Pattern Analysis - Newser
How hedge fund analytics apply to Leap Therapeutics Inc. stockStable Profit Zone and Loss Control Analysis - Newser
Top chart patterns to watch in Leap Therapeutics Inc.Smart Safety Strategy With Real Data Analysis - Newser
Leap Therapeutics Inc. stock retracement – recovery analysisFree Fundamental Growth Stock Analysis - Newser
Real time alert setup for Leap Therapeutics Inc. performanceFree AI Driven Buy Alert Trade Blueprint - Newser
Does Leap Therapeutics Inc. show high probability of reboundDeep Learning Stock Forecast for Investors - Newser
Applying Elliott Wave Theory to Leap Therapeutics Inc.Trend Confirmation Scanner with Entry Focus - Newser
Leap Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingConsistent Return Setup with Exit Strategy - Newser
What’s next for Leap Therapeutics Inc. stock priceDaily Stock Forecast Powered by AI Tools - Newser
How to recover losses in Leap Therapeutics Inc. stockMachine Learning Stock Movement Detector - Newser
How to integrate Leap Therapeutics Inc. into portfolio analysis toolsStable Profit Zone and Loss Control Analysis - Newser
Leap Therapeutics (LPTX) to Release Quarterly Earnings on Monday - Defense World
Pattern recognition hints at Leap Therapeutics Inc. upsideRapid Trade Forecast Based on Indicators - Newser
Leap Therapeutics LPTX 2025Q2 Earnings Preview Downside Concerns Amid Lack of Revenue Visibility - AInvest
Sector ETF performance correlation with Leap Therapeutics Inc.Fundamental Analysis for Value Stock Selection - Newser
Leap Therapeutics Inc Azioni (LPTX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):